Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis.
Mei QiuShu-Yan LiuHai-Rong ZhouPublished in: Medicine (2021)
Compared with TAT, DAT significantly reduces the risk of clinically significant bleeding and leads to the similar risk of MACE in patients with atrial fibrillation following PCI, irrespective of sex, age, race, history of diabetes, and type of P2Y12 inhibitor used at baseline.
Keyphrases
- atrial fibrillation
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- coronary artery disease
- type diabetes
- coronary artery bypass grafting
- cardiovascular disease
- heart failure
- glycemic control
- adipose tissue
- cerebral ischemia
- left ventricular
- insulin resistance